Catalyst Pharmaceuticals, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.49M0.50M102.31M119.07M140.83M214.20M398.20M491.73M
Cost of Revenue 14.76M17.04M21.88M34.39M51.97M68.84M
Gross Profit 0.49M0.50M87.55M102.03M118.95M179.81M346.24M422.89M
Operating items
Research & Development 5.10M2.31M3.38M2.66M8.10M10.12M11.80M11.37M11.38M19.92M18.84M16.50M16.94M19.79M93.15M12.65M
Selling, General & Administrative 2.18M2.21M2.70M2.56M2.21M4.47M8.60M7.91M7.30M15.88M36.88M44.23M49.63M57.09M133.71M177.74M
Other Operating Expenses 14.76M17.04M21.88M35.49M84.53M106.22M
Operating Expenses 7.28M4.51M6.08M5.22M10.31M14.59M20.40M19.28M18.68M35.80M70.48M77.77M88.45M112.36M311.39M296.61M
Operating Income -7.28M-4.02M-6.08M-5.22M-10.31M-14.59M-20.40M-19.28M-18.68M-35.30M31.82M41.30M52.38M101.84M86.81M195.12M
EBIT -7.28M-4.02M-6.08M-5.22M-10.31M-14.59M-20.40M-19.28M-18.68M-35.30M31.82M41.30M52.38M101.84M86.81M195.12M
Non-operating items
Interest & Investment Income 0.03M0.02M0.01M0.01M0.05M
Other Non Operating Income -0.32M0.01M0.05M0.08M0.10M0.32M0.45M1.29M1.59M0.59M0.28M2.88M7.70M21.14M
Non Operating Income 0.01M0.05M0.08M0.10M0.32M0.45M1.29M1.59M0.59M0.28M2.88M7.70M21.14M
Net income details
EBT -7.24M-4.01M-6.39M-4.08M-12.15M-15.51M-20.23M-18.07M-18.41M-34.00M33.41M41.89M52.67M104.72M94.51M216.26M
Tax Provisions 1.53M-33.09M13.19M21.64M34.98M52.88M
Profit After Tax -7.24M-4.01M-6.39M-4.08M-12.15M-15.51M-20.23M-18.07M-18.41M-34.00M31.88M74.98M39.48M83.08M71.41M163.89M
Income from Continuing Operations -7.24M-4.01M-6.39M-4.08M-12.15M-15.51M-20.23M-18.07M-18.41M-34.00M31.88M74.98M39.48M83.08M59.54M163.39M
Consolidated Net Income -7.24M-4.01M-6.39M-4.08M-12.15M-15.51M-20.23M-18.07M-18.41M-34.00M31.88M74.98M39.48M83.08M59.54M163.39M
Income towards Parent Company -7.24M-4.01M-6.39M-4.08M-12.15M-15.51M-20.23M-18.07M-18.41M-34.00M31.88M74.98M39.48M83.08M59.54M163.39M
Net Income towards Common Stockholders -7.24M-4.01M-6.39M-4.08M-12.15M-15.51M-20.23M-18.07M-18.41M-34.00M31.88M74.98M39.48M83.08M59.54M163.39M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M0.00M0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Shares Outstanding (Weighted Average) 18.04M21.65M24.70M34.75M54.15M69.12M82.82M82.87M85.23M102.74M103.05M103.65M103.12M105.65M117.86M119.27M
Shares Outstanding (Diluted Average) 102.63M106.02M106.24M107.80M111.38M113.75M
EBITDA -7.28M-4.02M-6.08M-5.22M-10.31M-14.59M-20.40M-19.28M-18.41M-34.02M31.91M75.00M39.30M83.25M71.40M163.94M
Tax Rate 4.59%25.03%20.66%37.01%24.45%